Tirzepatide (Zepbound) has shown the highest average weight loss in trials, at up to 21%, compared to about 14 to 18% for semaglutide (depending on form and dose) and 11% for oral orforglipron
Principal Investigator on ESKETINTRD3004: An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression.
The rapid industrialization and urbanization processes are gradually increasing the load of metal and metalloids such as Cd, Pb, Cr, As, Hg, Ni, Cu, Zn, and Co to agricultural soils [2]
. . .
This held promise for patients with intestinal paralysis following surgical intervention in the gastrointestinal tract, a condition called post-surgical ileus
Human research documented increased pigmentation through melanocortin-receptor signaling